Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8481510 Uracyl spirooxetane nucleosides

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Abdellah Tahri0

Koen Vandyck0

Lili Hu0

Pierre Jean-Marie Raboisson0

Steven Maurice Van Hoof0

Tim Hugo Maria Jonckers0

Date of Patent

July 9, 2013

0

Patent Application Number

133197350

Date Filed

May 11, 2010

0

Patent Citations Received

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 11707480 Highly active compounds against COVID-19

0

US Patent 11975016 2′-substituted-N

0

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

0

Patent Primary Examiner

Traviss C Mcintosh, III

0

Patent abstract

Compounds of the formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8481510 Uracyl spirooxetane nucleosides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool